MedPath

北京轩升制药有限公司

Ownership
-
Established
2021-08-25
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Esomeprazole Sodium for Injection

Product Name
注射用艾司奥美拉唑钠
Approval Number
国药准字H20253955
Approval Date
Apr 22, 2025
NMPA

Letrozole Tablets

Product Name
来曲唑片
Approval Number
国药准字H20249070
Approval Date
Oct 16, 2024
NMPA

Roxatidine Acetate Hydrochloride For Injection

Product Name
注射用盐酸罗沙替丁醋酸酯
Approval Number
国药准字H20120076
Approval Date
Aug 12, 2022
NMPA

Omeprazole Sodium for Injection

Product Name
注射用奥美拉唑钠
Approval Number
国药准字H20055755
Approval Date
Sep 24, 2021
NMPA

Pantoprazole Sodium for Injection

Product Name
注射用泮托拉唑钠
Approval Number
国药准字H20084309
Approval Date
Dec 31, 2019
NMPA

Pantoprazole Sodium for Injection

Product Name
注射用泮托拉唑钠
Approval Number
国药准字H20084310
Approval Date
Dec 31, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.